ClinFlows is proud to support the University Hospital Bonn in the investigator-initiated ATLAS/NOA-29 clinical trial with its secure, GDPR-compliant platform decidemedical.
The multicenter study will enrol 178 patients, comparing two surgical strategies for newly diagnosed temporal lobe glioblastoma: anterior temporal lobectomy (ATL) vs. gross total resection (GTR).
We believe academic research deserves the same digital standards as sponsored trials. ClinFlows supports non-commercial studies with special pricing, enabling the use of professional tools for therapy optimisation, side effect management, and rare disease research.
Additional services, such as central imaging reads and quality control, can be arranged through our network of research partners.
Are you planning an IIT? Let us know, and we will find a cost-effective solution together.